MONTGOMERY, Ala. and PRINCETON, N.J. and LONDON and BANGALORE, India, Aedesius Health, a division of AedesiusOne Ltd, and its biopharmaceutical development incubator AO BIO, which is focused on developing and commercializing neglected and needed therapies, devices, and diagnostics, today announced a comprehensive commercialization partnership with Indegene, a technology-led healthcare solutions provider. Through this multi-year, comprehensive partnership, Indegene will support the design and operationalisation around the commercial infrastructure for Aedesius Health and its projects, starting with commercialisation of several key assets in the AO BIO pipeline. Indegene’s Co-Commercialization model enables Aedesius Health and AO BIO to achieve their mission to reset
The post Aedesius Health and its lead biopharma company, AO BIO partner with Indegene for a comprehensive commercialization engagement appeared first on Pharma Mirror Magazine.
